Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design

Autores
Boechi, Leonardo; de Oliveira, César Augusto F.; Da Fonseca, Isabel; Kizjakina, Karina; Sobrado, Pablo; Tanner, John J.; McCammon, J. Andrew
Año de publicación
2013
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Trypanosoma cruzi is the causative agent of Chagas disease, a neglected tropical disease that represents one of the major health challenges of the Latin American countries. Successful efforts were made during the last few decades to control the transmission of this disease, but there is still no treatment for the 10 million adults in the chronic phase of the disease. In T. cruzi, as well as in other pathogens, the flavoenzyme UDP-galactopyranose mutase (UGM) catalyzes the conversion of UDP-galactopyranose to UDP-galactofuranose, a precursor of the cell surface β-galactofuranose that is involved in the virulence of the pathogen. The fact that UGM is not present in humans makes inhibition of this enzyme a good approach in the design of new Chagas therapeutics. By performing a series of computer simulations of T. cruzi UGM in the presence or absence of an active site ligand, we address the molecular details of the mechanism that controls the uptake and retention of the substrate. The simulations suggest a modular mechanism in which each moiety of the substrate controls the flexibility of a different protein loop. Furthermore, the calculations indicate that interactions with the substrate diphosphate moiety are especially important for stabilizing the closed active site. This hypothesis is supported with kinetics measurements of site-directed mutants of T. cruzi UGM. Our results extend our knowledge of UGM dynamics and offer new alternatives for the prospective design of drugs.
Fil: Boechi, Leonardo. University Of California At San Diego; Estados Unidos
Fil: de Oliveira, César Augusto F.. University Of California At San Diego; Estados Unidos
Fil: Da Fonseca, Isabel. Virginia Tech University; Estados Unidos
Fil: Kizjakina, Karina. Virginia Tech University; Estados Unidos
Fil: Sobrado, Pablo. Virginia Tech University; Estados Unidos
Fil: Tanner, John J.. University Of Missouri; Estados Unidos
Fil: McCammon, J. Andrew. University Of California At San Diego; Estados Unidos
Materia
Udp-Galactopyranose Mutase
Ugm
Molecular Dynamics
Accelerated Molecular Dynamics
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/15880

id CONICETDig_8aa83ff4d8764cc3c3468127f66d4e47
oai_identifier_str oai:ri.conicet.gov.ar:11336/15880
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug designBoechi, Leonardode Oliveira, César Augusto F.Da Fonseca, IsabelKizjakina, KarinaSobrado, PabloTanner, John J.McCammon, J. AndrewUdp-Galactopyranose MutaseUgmMolecular DynamicsAccelerated Molecular Dynamicshttps://purl.org/becyt/ford/1.4https://purl.org/becyt/ford/1Trypanosoma cruzi is the causative agent of Chagas disease, a neglected tropical disease that represents one of the major health challenges of the Latin American countries. Successful efforts were made during the last few decades to control the transmission of this disease, but there is still no treatment for the 10 million adults in the chronic phase of the disease. In T. cruzi, as well as in other pathogens, the flavoenzyme UDP-galactopyranose mutase (UGM) catalyzes the conversion of UDP-galactopyranose to UDP-galactofuranose, a precursor of the cell surface β-galactofuranose that is involved in the virulence of the pathogen. The fact that UGM is not present in humans makes inhibition of this enzyme a good approach in the design of new Chagas therapeutics. By performing a series of computer simulations of T. cruzi UGM in the presence or absence of an active site ligand, we address the molecular details of the mechanism that controls the uptake and retention of the substrate. The simulations suggest a modular mechanism in which each moiety of the substrate controls the flexibility of a different protein loop. Furthermore, the calculations indicate that interactions with the substrate diphosphate moiety are especially important for stabilizing the closed active site. This hypothesis is supported with kinetics measurements of site-directed mutants of T. cruzi UGM. Our results extend our knowledge of UGM dynamics and offer new alternatives for the prospective design of drugs.Fil: Boechi, Leonardo. University Of California At San Diego; Estados UnidosFil: de Oliveira, César Augusto F.. University Of California At San Diego; Estados UnidosFil: Da Fonseca, Isabel. Virginia Tech University; Estados UnidosFil: Kizjakina, Karina. Virginia Tech University; Estados UnidosFil: Sobrado, Pablo. Virginia Tech University; Estados UnidosFil: Tanner, John J.. University Of Missouri; Estados UnidosFil: McCammon, J. Andrew. University Of California At San Diego; Estados UnidosWiley2013-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/15880Boechi, Leonardo; de Oliveira, César Augusto F.; Da Fonseca, Isabel; Kizjakina, Karina; Sobrado, Pablo; et al.; Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design; Wiley; Protein Science; 22; 11; 11-2013; 1490-15010961-8368enginfo:eu-repo/semantics/altIdentifier/doi/10.1002/pro.2332info:eu-repo/semantics/altIdentifier/url/http://onlinelibrary.wiley.com/doi/10.1002/pro.2332/abstractinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:33:01Zoai:ri.conicet.gov.ar:11336/15880instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:33:01.302CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design
title Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design
spellingShingle Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design
Boechi, Leonardo
Udp-Galactopyranose Mutase
Ugm
Molecular Dynamics
Accelerated Molecular Dynamics
title_short Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design
title_full Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design
title_fullStr Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design
title_full_unstemmed Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design
title_sort Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design
dc.creator.none.fl_str_mv Boechi, Leonardo
de Oliveira, César Augusto F.
Da Fonseca, Isabel
Kizjakina, Karina
Sobrado, Pablo
Tanner, John J.
McCammon, J. Andrew
author Boechi, Leonardo
author_facet Boechi, Leonardo
de Oliveira, César Augusto F.
Da Fonseca, Isabel
Kizjakina, Karina
Sobrado, Pablo
Tanner, John J.
McCammon, J. Andrew
author_role author
author2 de Oliveira, César Augusto F.
Da Fonseca, Isabel
Kizjakina, Karina
Sobrado, Pablo
Tanner, John J.
McCammon, J. Andrew
author2_role author
author
author
author
author
author
dc.subject.none.fl_str_mv Udp-Galactopyranose Mutase
Ugm
Molecular Dynamics
Accelerated Molecular Dynamics
topic Udp-Galactopyranose Mutase
Ugm
Molecular Dynamics
Accelerated Molecular Dynamics
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.4
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Trypanosoma cruzi is the causative agent of Chagas disease, a neglected tropical disease that represents one of the major health challenges of the Latin American countries. Successful efforts were made during the last few decades to control the transmission of this disease, but there is still no treatment for the 10 million adults in the chronic phase of the disease. In T. cruzi, as well as in other pathogens, the flavoenzyme UDP-galactopyranose mutase (UGM) catalyzes the conversion of UDP-galactopyranose to UDP-galactofuranose, a precursor of the cell surface β-galactofuranose that is involved in the virulence of the pathogen. The fact that UGM is not present in humans makes inhibition of this enzyme a good approach in the design of new Chagas therapeutics. By performing a series of computer simulations of T. cruzi UGM in the presence or absence of an active site ligand, we address the molecular details of the mechanism that controls the uptake and retention of the substrate. The simulations suggest a modular mechanism in which each moiety of the substrate controls the flexibility of a different protein loop. Furthermore, the calculations indicate that interactions with the substrate diphosphate moiety are especially important for stabilizing the closed active site. This hypothesis is supported with kinetics measurements of site-directed mutants of T. cruzi UGM. Our results extend our knowledge of UGM dynamics and offer new alternatives for the prospective design of drugs.
Fil: Boechi, Leonardo. University Of California At San Diego; Estados Unidos
Fil: de Oliveira, César Augusto F.. University Of California At San Diego; Estados Unidos
Fil: Da Fonseca, Isabel. Virginia Tech University; Estados Unidos
Fil: Kizjakina, Karina. Virginia Tech University; Estados Unidos
Fil: Sobrado, Pablo. Virginia Tech University; Estados Unidos
Fil: Tanner, John J.. University Of Missouri; Estados Unidos
Fil: McCammon, J. Andrew. University Of California At San Diego; Estados Unidos
description Trypanosoma cruzi is the causative agent of Chagas disease, a neglected tropical disease that represents one of the major health challenges of the Latin American countries. Successful efforts were made during the last few decades to control the transmission of this disease, but there is still no treatment for the 10 million adults in the chronic phase of the disease. In T. cruzi, as well as in other pathogens, the flavoenzyme UDP-galactopyranose mutase (UGM) catalyzes the conversion of UDP-galactopyranose to UDP-galactofuranose, a precursor of the cell surface β-galactofuranose that is involved in the virulence of the pathogen. The fact that UGM is not present in humans makes inhibition of this enzyme a good approach in the design of new Chagas therapeutics. By performing a series of computer simulations of T. cruzi UGM in the presence or absence of an active site ligand, we address the molecular details of the mechanism that controls the uptake and retention of the substrate. The simulations suggest a modular mechanism in which each moiety of the substrate controls the flexibility of a different protein loop. Furthermore, the calculations indicate that interactions with the substrate diphosphate moiety are especially important for stabilizing the closed active site. This hypothesis is supported with kinetics measurements of site-directed mutants of T. cruzi UGM. Our results extend our knowledge of UGM dynamics and offer new alternatives for the prospective design of drugs.
publishDate 2013
dc.date.none.fl_str_mv 2013-11
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/15880
Boechi, Leonardo; de Oliveira, César Augusto F.; Da Fonseca, Isabel; Kizjakina, Karina; Sobrado, Pablo; et al.; Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design; Wiley; Protein Science; 22; 11; 11-2013; 1490-1501
0961-8368
url http://hdl.handle.net/11336/15880
identifier_str_mv Boechi, Leonardo; de Oliveira, César Augusto F.; Da Fonseca, Isabel; Kizjakina, Karina; Sobrado, Pablo; et al.; Substrate-dependent dynamics of UDP-galactopyranose mutase: implications for drug design; Wiley; Protein Science; 22; 11; 11-2013; 1490-1501
0961-8368
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1002/pro.2332
info:eu-repo/semantics/altIdentifier/url/http://onlinelibrary.wiley.com/doi/10.1002/pro.2332/abstract
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844614344927608832
score 13.070432